Prf Technologies Ltd stock is traded at $0.7588, with a volume of 95,531. It is down -0.81% in the last 24 hours and down -14.19% over the past month. PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.
Previous Close:
$0.765
Open:
$0.778
24h Volume:
95,531
Relative Volume:
0.21
Market Cap:
$2.66M
Revenue:
$17,000
Net Income/Loss:
-$5.02M
P/E Ratio:
-
EPS:
-$8.49
Net Cash Flow:
-$3.96M
1W Performance:
+1.15%
1M Performance:
-14.19%
6M Performance:
-60.68%
1Y Performance:
-86.45%
1-Day Range:
$0.74$0.8
1-Week Range:
$0.641$0.83
52-Week Range:
$0.641$7.95
Prf Technologies Ltd Stock (PRFX) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS